In Azle, Medicaid spending for services associated with HCPCS codes explicitly tied to COVID-19 amounted to a minimum of $74,958 in 2024, according to data in the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid is a government health insurance program overseen by states and funded with support from federal and state governments. The program provides health care to low-income people of all ages, including children, seniors, families, and individuals with disabilities, making it a major part of U.S. health care delivery.
Because Medicaid relies on taxpayer funding, fluctuations in local claim volume reflect shifts in how public health funding is distributed locally.
For this report, services were designated as COVID-19–related if their HCPCS codes were labeled or classified as “COVID-19” or “coronavirus” within billing records or reference data. These figures capture only those services specifically identified as related to COVID-19 and do not include all pandemic-related medical expenses billed under broader categories.
For contrast, Houston registered the highest total for Medicaid payments on COVID-19 services in Texas in 2024, submitting $5,684,946 in claims tied to the virus.
Two providers in Azle filed Medicaid claims for COVID-19–related services in 2024, with COVID Specific representing $58,725 of the claims—one of the highest for the area.
The average Medicaid payment per Azle provider for COVID-19 services was $37,479, beneath the Texas state average payment of $40,722 per provider.
During the pandemic years, expenditures on COVID-19–specific services were a notable factor in Medicaid spending growth in Azle.
Among all other categories, Medicaid payments in Azle rose by $463,738 over the period from 2020 to 2024, marking a 100.6% increase.
In the two years prior to the pandemic, annual Medicaid payments in the city averaged $447,774.
The Centers for Medicare & Medicaid Services reports that total federal and state spending for Medicaid reached $871.7 billion during fiscal year 2023—representing about 18% of all national health expenditures—an increase from approximately $613.5 billion in 2019, prior to the COVID-19 pandemic era.
This shift represents approximately 40% growth in spending, resulting from greater enrollment and increased usage of services related to the pandemic and subsequent periods.
Recent federal budget measures proposed and enacted during the Trump administration included major structural changes to Medicaid, such as the “One Big Beautiful Bill Act,” which lawmakers say will reduce federal Medicaid funding by more than $1 trillion across 10 years. Work requirements and enhanced cost-sharing rules are also written into law, potentially reducing funding and eligibility for part of the population and transferring increased costs to state governments, even as tens of millions remain served by Medicaid.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $74,958 | -52% | $999,774 |
| 2023 | $156,273 | 31.7% | $1,851,194 |
| 2022 | $118,695 | 25.2% | $1,998,120 |
| 2021 | $94,774 | 770.3% | $1,666,640 |
| 2020 | $10,889 | N/A | $471,968 |
| 2019 | $0 | N/A | $479,376 |
| 2018 | $0 | N/A | $416,172 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87635 | COVID Specific | $53,556 | 472 |
| 87811 | Immunoassay | $16,233 | 419 |
| U0002 | COVID Specific | $5,170 | 120 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
This article relies on information available from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Source data is available here.
